Press-release for stocks related to pharma

Prices are updated after-hours

tags : Pharma crawled time : 01:00

save search

United States Clinical Trials Support Services Market Analysis Reprot 2023-2028: Pharma & Biotech Companies Invest Heavily, Phase III Trials Anticipated to Showcase Highest Growth Rate
Published: 2023-10-18 (Crawled : 01:00) - prnewswire.com
ICLR | $288.32 -1.2% -1.21% 640K

Health Technology

| 21.37% | O: -1.23% H: 0.3% C: -3.38%
pharma companies services biotech trials growth market

HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
Published: 2023-06-01 (Crawled : 01:00) - globenewswire.com
HOOK | $0.7317 -4.34% -4.54% 420K

Health Technology

| -44.27% | O: -11.45% H: 11.21% C: -3.45%
pharma offering

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit
Published: 2023-04-26 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -33.89% | O: -0.43% H: 0.08% C: -1.35%
pharma business

Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
Published: 2023-04-19 (Crawled : 01:00) - prnewswire.com
INVA | $14.955 1.8% 1.77% 640K

Health Technology

| 31.14% | O: -0.53% H: 5.29% C: 4.5%
partnership pharma xerava commercialization china

Athira Pharma Reports Full Year 2022 Financial Results and Recent Pipeline and Business Updates
Published: 2023-03-23 (Crawled : 01:00) - biospace.com/
ATHA | $2.12 2.91% 2.83% 200K

Health Technology

| -14.46% | O: 0.0% H: 1.61% C: -3.61%
pharma business year pipeline financial results

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
Published: 2023-03-08 (Crawled : 01:00) - biospace.com/
FSTX | $7.12 0.0% 0

Health Technology

| -0.07% | O: -0.07% H: 0.0% C: 0.0%
MS | News | $90.66 0.44% 0.07% 8.1M

Finance

| -5.62% | O: -0.44% H: 0.9% C: 0.27%
acquisition pharma

Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023
Published: 2023-03-08 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.62% | O: -0.93% H: 0.0% C: 0.0%
pharma global preclinical biotech

Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023: Including Over 2900 Partnering Deals and Comprehensive Analysis
Published: 2023-03-06 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -3.0% | O: 0.65% H: 0.0% C: 0.0%
pharma global biotech

Microbiomes market size to grow at a CAGR of 21.95% by 2027, Evolving Opportunities with 4D pharma Plc, AOBiome LLC, among others - Technavio
Published: 2023-02-21 (Crawled : 01:00) - prnewswire.com
PHGE | $0.2852 -3.58% 3.16% 69K

Health Technology

| -17.14% | O: 6.71% H: 0.0% C: -8.06%
pharma market

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
Published: 2022-12-04 (Crawled : 01:00) - ir.therapeuticsmd.com
TXMD | News | $1.86 -1.59% -1.61% 10K

Health Technology

| -58.2% | O: 2.25% H: 33.41% C: 12.53%
pharma license

Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
Published: 2022-08-15 (Crawled : 01:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K

Consumer Non-Durables

| -37.32% | O: 2.74% H: 0.0% C: -0.69%
PPRUY | $36.0023 -0.11% 220K

Manufacturing

| -37.7% | O: -1.23% H: 0.33% C: 0.16%
ATHA | $2.12 2.91% 2.83% 200K

Health Technology

| -45.38% | O: -0.77% H: 1.81% C: 0.78%
pharma results

Acasti Pharma Reports First Quarter 2023 Operational Results
Published: 2022-08-11 (Crawled : 01:00) - globenewswire.com
ACST | $3.07 -3.91% 20K

Health Technology

| -46.13% | O: -0.9% H: 5.16% C: 2.27%
pharma results

Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
Published: 2022-08-11 (Crawled : 01:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K

Health Technology

| 44.22% | O: 9.17% H: 9.24% C: -0.84%
offering pharma

Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published: 2022-07-19 (Crawled : 01:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 125.72% | O: 0.72% H: 1.02% C: 0.65%
INCY | $52.3 -0.98% -0.99% 2.2M

Health Technology

| -34.97% | O: -0.83% H: 0.0% C: 0.0%
treatment designation pharma drug application granted review china

Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published: 2022-07-20 (Crawled : 01:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 122.66% | O: 0.27% H: 0.22% C: -1.55%
INCY | $52.3 -0.98% -0.99% 2.2M

Health Technology

| -34.42% | O: 2.32% H: 1.21% C: 0.99%
treatment designation pharma drug application granted review china

Female Infertility Drugs Market to Grow by USD 538.69 mn | AbbVie Inc. and Aurobindo Pharma Ltd. Among Key Vendors | Technavio
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -5.03% | O: -3.62% H: 0.0% C: -0.56%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 16.83% | O: 0.69% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 16.78% | O: 0.17% H: 0.5% C: -0.43%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 32.92% | O: 0.49% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -4.73% | O: -0.51% H: 0.0% C: 0.0%
ema drug pharma

Oyster Point Pharma to Participate in the Piper Sandler 33rd Annual Healthcare Conference
Published: 2021-12-01 (Crawled : 01:00) - globenewswire.com
OYST | $11.17 0.18% -0.27%

Health Technology

| 5.39% | O: -1.13% H: 2.06% C: -2.01%
conference pharma

Athira Pharma Announces Pricing of Public Offering of Common Stock
Published: 2021-01-21 (Crawled : 01:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K

Health Technology

| -91.24% | O: -6.13% H: 1.62% C: -11.21%
offering publication pharma

Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-11 (Crawled : 01:00) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K

Health Technology

| -17.09% | O: 0.02% H: 4.78% C: 2.51%
j.p. morgan healthcare conference pharma

Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
Published: 2021-01-09 (Crawled : 01:00) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K

Health Technology

| Email alert Add to watchlist
pharma